Strive sues Eli Lilly and Novo Nordisk over GLP-1 access
Strive Compounding Pharmacy accuses drugmakers of anti-competitive actions to suppress lawful compounded GLP-1 medications and restrict patient choice.
Strive Compounding Pharmacy accuses drugmakers of anti-competitive actions to suppress lawful compounded GLP-1 medications and restrict patient choice.
For retailers and pharmacists, the findings underscore the opportunity to educate shoppers as interest in supplements rises in 2026.
The 16-week observational study, called FIBER-IMPACT, will enroll 60 healthy adults and their household members.
Scanlon began her Publix career in 2007 as a floating pharmacist in Sandy Springs, Georgia.
Kroger stated that the divestiture is part of a broader review of non-core assets as the company progresses with priorities.
Better Care Services connects customers to a network of third-party providers for urgent care and behavioral health.
CHPA appreciates the ongoing recognition that dietary supplements support individuals in meeting nutrient needs when diet alone falls short.
A survey found no significant change in intentional misuse of OTC cough and cold meds across grades.
The trade group said the updated guidelines balance prioritizing nutrient-dense foods and recognizing supplements as a science-based option to support public health.
“Pharmacy remains a key growth driver for us,” says CEO Susan Morris.
Together, the two innovations expand L’Oréal’s growing lineup of light-based Beauty Tech solutions.
A new feature in the Libre app helps people with diabetes make informed, real-time food choices before eating.
The approval expands the Wegovy portfolio beyond injections, providing a new administration option for patients.
The Council for Responsible Nutrition announced its 2026 Board of Directors as it gears up for increased regulation and legislation.
The end of enhanced ACA premium support in 2026 will likely push millions off marketplace plans, increasing uninsured visits to safety-net clinics and assistance programs.
CHPA said the bill would boost OTC market innovation by clarifying and standardizing the review process for new and updated self-care products.